Jan 30 (Reuters) - Dr. Lal Path Labs (DLPA.NS), opens new tab reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand ...
April 30 (Reuters) - Dr Lal Path Labs reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses. Here are some details: • Consolidated net profit fell to 1.31 billion ...
Hosted on MSN
Dr Lal PathLabs reports 16% rise in Q2 profit, declares Rs.7 interim dividend and 1:1 bonus issue
Mumbai, Oct. 31 -- Dr Lal PathLabs Limited reported consolidated revenue of Rs.731 crore for the second quarter of FY2025-26, marking a 10.7% year-on-year increase, while profit after tax (PAT) rose ...
Risks remain around pricing pressure in a competitive diagnostics market, continued cost pressures, and execution risks in scaling newer segments ...
NDTV Profit on MSN
Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results — Here's Why
The brokerage highlighted that network expansion, entry into high-end radiology and geographic diversification remain key growth drivers for Dr. Lal, though near-term risks include rising competition, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results